Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation

Jennifer Doudna, the Nobel Prize-winning scientist known for developing Crispr gene-editing, expressed skepticism regarding artificial intelligence’s capacity to replace human ingenuity in scientific breakthroughs. She suggests that while technology assists in data processing, fundamental innovation remains dependent on human expertise and laboratory verification.